Françis Mégraud

Université de Bordeaux — France

Medicine · Health Sciences

98h-index45.9kcitations799works20.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Helicobacter pylori-related gastroenterology studies(552), Veterinary medicine and infectious diseases(172), Gastric Cancer Management and Outcomes(157), Eosinophilic Esophagitis(126), Gastroesophageal reflux and treatments(102)

Publications789 total

Nomenclatural Recommendations for Genera Assigned to the Arcobacteraceae from the Subcommittee on the Taxonomy of Campylobacter and Related Bacteria
Bacteria·2026Open Access
Genomic determinants of antibiotic resistance for Helicobacter pylori treatment: a retrospective phenotypic and genotypic observational study
The Lancet Microbe·2025Open Access
Comparison between optimized bismuth quadruple therapy and standard clarithromycin-based triple therapy for first-line Helicobacter pylori eradication: a double-blind randomized controlled trial
The Lancet Regional Health - Americas·2025Open Access
Publisher Correction: Academia Europaea’s guidelines for the visualization of clinical outcomes
Nature Medicine·2025Open Access
Academia Europaea’s guidelines for the visualization of clinical outcomes
Nature Medicine·2025
Screening and eradication of <i>Helicobacter pylori f</i> or gastric cancer prevention: Taipei Global Consensus II
Gut·2025· 10 cited
Second‐ and Third‐Line Therapies for <i>Helicobacter pylori</i> Eradication in Slovenia: Data From 2013–2023 of the European Registry on <i>H. pylori</i> Management
Helicobacter·2025
Real-World-Daten zur Erstlinientherapie der Helicobacter pylori-Eradikation in Deutschland: Ergebnisse aus dem Hp-EuReg mit Fokus auf die Prävention des Magenkarzinoms
Zeitschrift für Gastroenterologie·2025
Effectiveness and safety of first-line empirical Helicobacter pylori eradication regimens in Switzerland: an interim analysis from a prospective multicentre registry (Hp-EuReg)
Swiss Medical Weekly·2025Open Access
<i>Helicobacter pylori</i> antibiotic resistance: a global challenge in search of solutions
Gut·2025· 26 cited
First-Line Prescriptions and Effectiveness of Helicobacter pylori Eradication Treatment in Ireland over a 10-Year Period: Data from the European Registry on Helicobacter pylori Management (Hp-EuReg)
Antibiotics·2025· 1 citedOpen Access
Effectiveness and Safety of First‐Line Non‐Bismuth Quadruple Concomitant Therapy Versus Single‐Capsule Bismuth Quadruple Therapy
Alimentary Pharmacology & Therapeutics·2025· 5 cited
<scp><i>Helicobacter pylori</i></scp> Infection in Children Versus Adults, Differences in Management Guidelines: Risks and Benefits of Treatment in Childhood
Helicobacter·2025Open Access
Real‐Time <scp>PCR</scp><i>Helicobacter pylori</i> Test in Comparison With Culture and Histology for <i>Helicobacter pylori</i> Detection and Identification of Resistance to Clarithromycin: A Single‐Center Real‐Life Study
Helicobacter·2025· 1 citedOpen Access
First‐Line Therapy for <scp><i>Helicobacter pylori</i></scp> in Slovenia: Data From 2013 to 2023 of the European Registry on <scp><i>H. pylori</i></scp> Management
Helicobacter·2025· 2 cited
Chronic Infection With Gastric <i>Helicobacters</i> Induces Hepatic Lesions in Mice
Helicobacter·2025· 1 citedOpen Access
Probiotics Prescribed With Helicobacter pylori Eradication Therapy in Europe: Usage Pattern, Effectiveness, and Safety. Results From the European Registry on Helicobacter pylori Management (Hp-EuReg)
The American Journal of Gastroenterology·2025· 8 cited
The implementation of PCR-guided therapy in the eradication of Helicobacter pylori: experience from the European Registry on H. pylori management (Hp-EuReg)
Revista Española de Enfermedades Digestivas·2025
Effectiveness of First-Line Empirical Treatment in Portugal: Data from the European Registry on Helicobacter pylori Management
GE Portuguese Journal of Gastroenterology·2024· 2 citedOpen Access
International consensus statement on microbiome testing in clinical practice
˜The œLancet. Gastroenterology & hepatology·2024· 58 citedOpen Access
page 1 of 40Next →

Frequent Co-authors

Peter Malfertheiner(14), Colm O’Morain(9), Emad El‐Omar(6), Javier P. Gisbert(5), Anthony Axon(5), David Y. Graham(5), H Lamouliatte(5), Ernst J. Kuipers(4), Franco Bazzoli(4), Antonio Gasbarrini(4), Theodore Rokkas(4), Kentaro Sugano(4), J. Atherton(3), Sebastian Suerbaum(3), Jyh‐Ming Liou(3), Mārcis Leja(3), Tamara Matysiak‐Budnik(3), Fátima Carneiro(3), Y. Glupczynski(3), Sibylle Koletzko(3)